Medicine Overview

Indication

Know Medicine, Follow Guideline

Adult Dose

Clinical InformationAdministration Information
Indication: Short-term management of insomnia
Age: Adult
Dose: Oral – 7.5 mg
Frequency: at bedtime
Indication: Short-term management of insomnia
Age: Elderly
Dose: Oral – 3.75 mg
Frequency: at bedtime
Note: Initially

Child Dose

Clinical InformationAdministration Information
Age: Child
Dose: No approved pediatric dosage available
Note: Not recommended

Renal Dose

Clinical InformationAdministration Information
Condition: Renal impairment
Dose: Tablet – 3.75 mg
Frequency: at bedtime
Note: Initiate at 3.75 mg at bedtime for renal impairment.
Administration
  • Can be taken with or without food
  • Take just before bedtime
Side Effect

Drug Interaction

Drug NameRisk Factors
Phenytoin, carbamazepine
Reduced hypnotic effect
TCAs
Increased drowsiness and incoordination

Disease Interaction

Disease NameRisk Factors
Myasthenia Gravis
Can worsen muscle weakness
Respiratory Failure
Risk of respiratory depression

Pregnancy

Lactation
Special Use
Precaution
Overdose
Pharmacology
Storage
Store in a dry place, at room temperature (15°C to 30°C). Protect from light. Keep in a safe place out of reach of children.

Data Sources

Clinical & regulatory information on this page is compiled from the following government sources:

DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment.